Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages.

MLA

Raudszus, Rick, et al. “Pharmacological Inhibition of TRPV2 Attenuates Phagocytosis and Lipopolysaccharide-Induced Migration of Primary Macrophages.” British Journal of Pharmacology, vol. 180, no. 21, Nov. 2023, pp. 2736–49. EBSCOhost, https://doi.org/10.1111/bph.16154.

APA

Raudszus, R., Paulig, A., Urban, N., Deckers, A., Gräßle, S., Vanderheiden, S., Jung, N., Bräse, S., Schaefer, M., & Hill, K. (2023). Pharmacological inhibition of TRPV2 attenuates phagocytosis and lipopolysaccharide-induced migration of primary macrophages. British Journal of Pharmacology, 180(21), 2736–2749. https://doi.org/10.1111/bph.16154

Chicago

Raudszus, Rick, Andrea Paulig, Nicole Urban, Anke Deckers, Simone Gräßle, Sylvia Vanderheiden, Nicole Jung, Stefan Bräse, Michael Schaefer, and Kerstin Hill. 2023. “Pharmacological Inhibition of TRPV2 Attenuates Phagocytosis and Lipopolysaccharide-Induced Migration of Primary Macrophages.” British Journal of Pharmacology 180 (21): 2736–49. doi:10.1111/bph.16154.